International Clinical Trial: The efficacy and safety of metformin intervention in elderly overweight or obesity with mild cognitive impairment

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132779) titled 'The efficacy and safety of metformin intervention in elderly overweight or obesity with mild cognitive impairment' on Sept. 18.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Huadong Hospital, Fudan University

Condition: Overweight or obesity with mild cognitive impairment

Intervention: Metformin group:Take metformin sustained-release tablets orally (once a day, 1500mg each time. If intolerable, reduce the dosage to the maximum tolerated amount) for 26 weeks and diet and exercise for 26 weeks

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2025-09-01 ...